dexmedetomidine has been researched along with dantrolene in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Code, WE; Hertz, L; Zhao, Z | 1 |
| Guruli, ZV; Ramadhyani, U; Shukry, M | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for dexmedetomidine and dantrolene
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for dexmedetomidine and dantrolene
| Article | Year |
|---|---|
A correlation between dexmedetomidine-induced biphasic increases in free cytosolic calcium concentration and energy metabolism in astrocytes.
Topics: Adjuvants, Anesthesia; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Astrocytes; Calcium; Cells, Cultured; Cerebral Cortex; Cytosol; Dantrolene; Dexmedetomidine; Dose-Response Relationship, Drug; Energy Metabolism; Hypnotics and Sedatives; Idazoxan; Mice; Muscle Relaxants, Central; Pyruvic Acid; Yohimbine | 2000 |
Suspected malignant hyperthermia in a child with laminin alpha2 (merosin) deficiency in the absence of a triggering agent.
Topics: Anesthesia, Intravenous; Child; Dantrolene; Dexmedetomidine; Humans; Laminin; Male; Malignant Hyperthermia; Muscle Relaxants, Central; Muscular Dystrophies; Phenotype | 2006 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |